The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Human tumor antigens recognized by T lymphocytes.
Open accessAbstract
W e have come a long way since the identification of the first human tumor antigen recognized by autologous CTL.This report provides a brief appraisal of these antigens and their potential for cancer immunotherapy.Our comments will be restricted to nonviral antigens.The initial work carried out on mouse tumors revealed two possible mechanisms for generating new antigens that might be suflficiendy tumor-specific to be of relevance to immunotherapy.The first mechanism involved a point mutation, and the second involved the transcriptional activation ofa gene not expressed in normal tissues (1-3).Subsequent work on mouse tumors provided two interesting examples of tumor antigens resulting from point mutations (4, 5).Tumor-specific Shared Antigens.Three families of genes that appear to code for highly specific tumor antigens have been identified so far, namely, the MAGE, BAGE, and GAGE genes (6-9).These genes are frequently expressed in a wide range of tumor types such as melanoma, lung carcinoma, sarcoma, and bladder carcinoma, but very rarely in other tumor types such as brain tumors, renal carcinoma, and leukemia (7,(10)(11)(12).The only normal tissues where expression of these genes has been observed are testis and placenta (7).Starting from CTL clones obtained by stimulating lymphocytes with an autologous melanoma cell line, six antigens encoded by MAGE-1, BAGE, and GAGE have been identified (8,9,[13][14][15].For these six an-
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., & Boon, T. (1991) · Science · doi:10.1126/science.1840703 · Cited by 3,545
Self-citationMHC ligands and peptide motifs: first listing
Rammensee, H.-G., Friede, T., & Stevanović, S. (1995) · Immunogenetics · doi:10.1007/bf00172063 · Cited by 1,638
A p16 INK4a -Insensitive CDK4 Mutant Targeted by Cytolytic T Lymphocytes in a Human Melanoma
Wölfel, T., Hauer, M., Schneider, J., Serrano, M., Wölfel, C., Klehmann-Hieb, E., De Plaen, E., Hankeln, T., Meyer zum Büschenfelde, K.-H., & Beach, D. (1995) · Science · doi:10.1126/science.7652577 · Cited by 1,154
Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3515 · Cited by 1,092
Brichard, V, Van Pel, A., Wölfel, T., Wölfel, C., De Plaen, E., Lethé, B., Coulie, P., & Boon, T. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.489 · Cited by 950
Self-citationKawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6458 · Cited by 914
Coulie, P. G., Brichard, V, Van Pel, A., Wölfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J. P., et al. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.35 · Cited by 903
Self-citationKawakami, Y., Eliyahu, S., Sakaguchi, K., Robbins, P. F., Rivoltini, L., Yannelli, J. R., Appella, E., & Rosenberg, S. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.347 · Cited by 862
Identification of a Peptide Recognized by Five Melanoma-Specific Human Cytotoxic T Cell Lines
Cox, A. L., Skipper, J., Chen, Y., Henderson, R. A., Darrow, T. L., Shabanowitz, J., Engelhard, V. H., Hunt, D. F., & Slingluff, C. L. (1994) · Science · doi:10.1126/science.7513441 · Cited by 824
Gaugler, B., Van den Eynde, B., van der Bruggen, P., Romero, P., Gaforio, J. J., De Plaen, E., Lethé, B., Brasseur, F., & Boon, T. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.921 · Cited by 762
Self-citationTraversari, C., van der Bruggen, P., Luescher, I. F., Lurquin, C., Chomez, P., Van Pel, A., De Plaen, E., Amar-Costesec, A., & Boon, T. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.5.1453 · Cited by 679
Self-citationBakker, A. B., Schreurs, M. W., de Boer, A. J., Kawakami, Y., Rosenberg, S. A., Adema, G. J., & Figdor, C. G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.3.1005 · Cited by 589
Structure, chromosomal localization, and expression of 12 genes of the MAGE family
De Plaen, E., Traversari, C., Gaforio, J. J., Szikora, J.-P., De Smet, C., Brasseur, F., van der Bruggen, P., Lethé, B., Lurquin, C., Chomez, P., et al. (1994) · Immunogenetics · doi:10.1007/bf01246677 · Cited by 586
Self-citationBAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes
Boël, P., Wildmann, C., Sensi, M. L., Brasseur, R., Renauld, J.-C., Coulie, P., Boon, T., & van der Bruggen, P. (1995) · Immunity · doi:10.1016/s1074-7613(95)80053-0 · Cited by 583
Self-citationGendler, S., Taylor-Papadimitriou, J., Duhig, T., Rothbard, J., & Burchell, J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37632-4 · Cited by 568
Van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S., & Boon, T. (1995) · The Journal of experimental medicine · doi:10.1084/jem.182.3.689 · Cited by 567
Self-citationRobbins, P. F., El-Gamil, M., Li, Y. F., Kawakami, Y., Loftus, D., Appella, E., & Rosenberg, S. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1185 · Cited by 550 · cited 1×
“This mutation creates an anchor residue enabling the peptide to bind to HLA-A24 ( 44 ).”
Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X., Southwood, S., Robbins, P. F., Sette, A., Appella, E., & Rosenberg, S. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.3961 · Cited by 540
Peoples, G. E., Goedegebuure, P. S., Smith, R., Linehan, D. C., Yoshino, I., & Eberlein, T. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.2.432 · Cited by 439
Coulie, P. G., Lehmann, F., Lethé, B., Herman, J., Lurquin, C., Andrawiss, M., & Boon, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.7976 · Cited by 423
Self-citationTumor regression responses in melanoma patients treated with a peptide encoded by gene MAGES‐3
Marchand, M., Weynants, P., Rankin, E., Arienti, F., Belli, F., Parmiani, G., Cascinelli, N., Bourlond, A., Vanwuck, R., Humblet, Y., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630622 · Cited by 417
Self-citationTwo tyrosinase nonapeptides recognized on HLA‐A2 melanomas by autologous cytolytic T lymphocytes
Wölfel, T., Van Pel, A., Brichard, V., Schneider, J., Seliger, B., Zum Büschenfelde, K. M., & Boon, T. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240340 · Cited by 411
Self-citationvan der Bruggen, P., Bastin, J., Gajewski, T., Coulie, P. G., Boël, P., De Smet, C., Traversari, C., Townsend, A., & Boon, T. (1994) · European Journal of Immunology · doi:10.1002/eji.1830241218 · Cited by 367
Self-citationDe Plaen, E., Lurquin, C., Van Pel, A., Mariamé, B., Szikora, J. P., Wölfel, T., Sibille, C., Chomez, P., & Boon, T. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.7.2274 · Cited by 308
Self-citationCelis, E., Tsai, V, Crimi, C., DeMars, R., Wentworth, P. A., Chesnut, R. W., Grey, H. M., Sette, A., & Serra, H. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2105 · Cited by 306
Lurquin, C., Van Pel, A., Mariamé, B., De Plaen, E., Szikora, J.-P., Janssens, C., Reddehase, M. J., Lejeune, J., & Boon, T. (1989) · Cell · doi:10.1016/0092-8674(89)90844-1 · Cited by 300
Self-citationVan den Eynde, B., Lethé, B., Van Pel, A., De Plaen, E., & Boon, T. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.6.1373 · Cited by 298
Self-citationTopalian, S. L., Rivoltini, L., Mancini, M., Markus, N. R., Robbins, P. F., Kawakami, Y., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9461 · Cited by 286
Expression of MAGE genes in primary and metastatic cutaneous melanoma
Brasseur, F., Rimoldi, D., Liénard, D., Lethé, B., Carrel, S., Arienti, F., Suter, L., Vanwijck, R., Bourlond, A., Humblet, Y., et al. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910630313 · Cited by 285
Self-citationWang, R. F., Robbins, P. F., Kawakami, Y., Kang, X. Q., & Rosenberg, S. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.2.799 · Cited by 270
Sequential chemoimmunotherapy in the treatment of metastatic melanoma.
Richards, J. M., Mehta, N., Ramming, K., & Skosey, P. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.8.1338 · Cited by 257
CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma
Mandelboim, O., Berke, G., Fridkin, M., Feldman, M., Eisenstein, M., & Eisenbach, L. (1994) · Nature · doi:10.1038/369067a0 · Cited by 254
Robbins, P. F., El‐Gamil, M., Kawakami, Y., Stevens, E., Yannelli, J. R., & Rosenberg, S. A. (1994) · PubMed · Cited by 248
A unique tumor antigen produced by a single amino acid substitution
Monach, P. A., Meredith, S. C., T.Siegel, C., & Schreiber, H. (1995) · Immunity · doi:10.1016/1074-7613(95)90078-0 · Cited by 241
Guilloux, Y., Lucas, S., Brichard, V. G., Van Pel, A., Viret, C., De Plaen, E., Brasseur, F., Lethé, B., Jotereau, F., & Boon, T. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.3.1173 · Cited by 230
Self-citationBruggen, P. V. D., Szikora, J., Boël, P., Wildmann, C., Somville, M., Sensi, M., & Boon, T. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240930 · Cited by 228
Self-citationExpression of mage genes by non‐small‐cell lung carcinomas
Weynants, P., Lethé, B., Brasseur, F., Marchand, M., & Boon, T. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910560612 · Cited by 228
Self-citationIdentification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis.
Takahashi, K., Shichijo, S., Noguchi, M., Hirohata, M., & Itoh, K. (1995) · PubMed · doi:10.11501/3108620 · Cited by 221
Prognostic significance of hypopigmentation in malignant melanoma
Bystryn, J. ‐. (1987) · Archives of Dermatology · doi:10.1001/archderm.123.8.1053 · Cited by 176
Jerome, K. R., Domenech, N., & Finn, O. J. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.3.1654 · Cited by 175
A mouse mutant p53 product recognized by CD4+ and CD8+ T cells.
Noguchi, Y., Chen, Y. T., & Old, L. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3171 · Cited by 173
Prognostic Significance of Hypopigmentation in Malignant Melanoma
Bystryn, J.-C. (1987) · Archives of Dermatology · doi:10.1001/archderm.1987.01660320095019 · Cited by 171
Structure and expression of the human polymorphic epithelial mucin gene: an expressed VNTR unit
Lancaster, C. A., Peat, N., Duhig, T., Wilson, D. B., Taylor‐Papadimitriou, J., & Gendler, S. J. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80888-5 · Cited by 151
Disis, M. L., Smith, J. W., Murphy, A. E., Chen, W., & Cheever, M. A. (1994) · PubMed · Cited by 148
Robbins, P. F., El‐Gamil, M., Li, Y. F., Topalian, S. L., Rivoltini, L., Sakaguchi, K., Appella, E., Kawakami, Y., & Rosenberg, S. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.11.5944 · Cited by 140
Brichard, V. G., Herman, J., Pel, A. V., Wildmann, C., Gaugler, B., Wölfel, T., Boon, T., & Lethé, B. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260135 · Cited by 131
Self-citationIoannides, C. G., Fisk, B. A., Fan, D., Biddison, W. E., Wharton, J. T., & O’Brian, C. A. (1993) · Cellular Immunology · doi:10.1006/cimm.1993.1233 · Cited by 118
Distribution of Human Leukocyte Antigen‐ABC and ‐D/DR Antigens in the Unfixed Human Testis
Haas, G. G., D’Cruz, O. J., & Bault, L. E. D. (1988) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1988.tb00234.x · Cited by 105
Herman, J., van der Bruggen, P., Luescher, I. F., Mandruzzato, S., Romero, P. J., Thonnard, J., Fleischhauer, K., Boon, T., & Coulie, P. G. (1996) · Immunogenetics · doi:10.1007/bf02199806 · Cited by 104
Self-citationp53, a potential target for tumor-directed T cells
Nijman, H. W., van der Burg, S. H., Vicrboom, M. P. M., Houbiers, J. G. A., Kast, W. M., & Melief, C. J. M. (1994) · Immunology Letters · doi:10.1016/0165-2478(94)90189-9 · Cited by 86
van Elsas, A., Nijman, H. W., van der Minne, C. E., Mourer, J. S., Kast, W. M., Melief, C. J. M., & Schrier, P. I. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910610319 · Cited by 83
Fossum, B., Olsen, A. C., Thorsby, E., & Gaudernack, G. (1995) · Cancer Immunology Immunotherapy · doi:10.1007/bf01517348 · Cited by 61
Oligopeptide Induction of a Cytotoxic T Lymphocyte Response to HER-2/Neu Proto-oncogene in Vitro
Fisk, B. A., Chesak, B., Pollack, M. S., Wharton, J. T., & Ioannides, C. G. (1994) · Cellular Immunology · doi:10.1006/cimm.1994.1238 · Cited by 40
The SMAGE gene family is expressed in post-meiotic spermatids during mouse germ cell differentiation
Chomez, P., Williams, R., Backer, O. D., Boon, T., & Vennström, B. (1995) · Immunogenetics · doi:10.1007/bf00186613 · Cited by 32
Self-citationGedde‐Dahl, T., Spurkland, A., Fossum, B., Thorsby, E., Gaudernack, G., & Wittinghofer, A. (1994) · European Journal of Immunology · doi:10.1002/eji.1830240221 · Cited by 31
Sequential Chemoimmunotherapy in the Treatment of Metastatic Melanoma
Richards, J. M., Mehta, N., Ramming, K., et al. (1992) · Springer eBooks · doi:10.1007/978-3-642-48715-6_91 · Cited by 16
Cited by
The Three Es of Cancer Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104803 · Cited by 3,072
The Immunobiology of Cancer Immunosurveillance and Immunoediting
Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.017 · Cited by 3,032
Zitvogel, L., Regnault, A., Lozier, A., Wolfers, J., Flament, C., Tenza, D., Ricciardi-Castagnoli, P., Raposo, G., & Amigorena, S. (1998) · Nature Medicine · doi:10.1038/nm0598-594 · Cited by 2,266
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming
Wolfers, J., Lozier, A., Raposo, G., Regnault, A., Théry, C., Masurier, C., Flament, C., Pouzieux, S., Faure, F., Tursz, T., et al. (2001) · Nature Medicine · doi:10.1038/85438 · Cited by 1,640
Cytokines in cancer pathogenesis and cancer therapy
Dranoff, G. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1252 · Cited by 1,573
Metadata
- Authors
- Boon, T., & van der Bruggen, P.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1996-03-01
- Volume
- 183
- Issue
- 3
- Pages
- 725-729
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2127468351
- Cited by
- 842
- References
- 56
- FWCI
- 19.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.